Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
Item number | Size | Datasheet | Manual | SDS | Delivery time | Quantity | Price |
---|---|---|---|---|---|---|---|
Cay26424-500 | 500 µg | - |
6 - 10 business days* |
331.00€
|
|||
Cay26424-1 | 1 mg | - |
6 - 10 business days* |
627.00€
|
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Imiquimod-d9 is intended for use as an internal standard for the quantification of imiquimod... more
Product information "Imiquimod-d9"
Imiquimod-d9 is intended for use as an internal standard for the quantification of imiquimod (Cay-14956) by GC- or LC-MS. Imiquimod is an imidazoquinoline agonist of toll-like receptor 7 (TLR7, EC50 = 2.12 µM). It increases TNF-alpha and IL-12 p40 production in IFN-gamma-treated murine peritoneal macrophages in a concentration- and MyD88-dependent manner. Topical application of imiquimod (30 µl of 5% cream) increases TNF and IFN levels at the application site in hairless mice. Imiquimod dose-dependently increases serum levels of IFN-alpha in mice when administered by gavage. It reduces tumor growth in an MC-26 model of murine colon cancer when administered at a dose of 30 mg/kg every three days. Imiquimod (5 mg/kg, intravaginally, twice daily) reduces vaginal viral titer and lesion formation in a guinea pig model of genital HSV-2 infection. Formulations containing imiquimod have been used in the treatment of actinic keratosis, superficial basal cell carcinoma, and external genital warts.Formal Name: 1-(2-(methyl-d3)propyl-1,1,2,3,3,3-d6)-1H-imidazo[4,5-c]quinolin-4-amine. CAS Number: 2712126-48-0. Molecular Formula: C14H7D9N4. Formula Weight: 249.4. Purity: >99% deuterated forms (d1-d9). Formulation: (Request formulation change), A solid. Solubility: DMF: 1 mg/ml, DMSO: 1 mg/ml. SMILES: NC1=NC2=C(C3=C1N=CN3C([2H])([2H])C(C([2H])([2H])[2H])([2H])C([2H])([2H])[2H])C=CC=C2. InChi Code: InChI=1S/C14H16N4/c1-9(2)7-18-8-16-12-13(18)10-5-3-4-6-11(10)17-14(12)15/h3-6,8-9H,7H2,1-2H3,(H2,15,17)/i1D3,2D3,7D2,9D. InChi Key: DOUYETYNHWVLEO-UEZIPFSLSA-N.
Keywords: | 1-(2-(methyl-d3)propyl-1,1,2,3,3,3-d6)-1H-imidazo[4,5-c]quinolin-4-amine |
Supplier: | Cayman Chemical |
Supplier-Nr: | 26424 |
Properties
Application: | GC-MS, LC-MS, quantification, internal standard, TLR7 activator |
MW: | 249.4 D |
Formula: | C14H7D9N4 |
Purity: | >99% deuterated forms (d1-d9) |
Format: | Solid |
Database Information
CAS : | 2712126-48-0| Matching products |
KEGG ID : | K05404 | Matching products |
Handling & Safety
Storage: | -20°C |
Shipping: | +20°C (International: -20°C) |
Signal Word: | Warning |
GHS Hazard Pictograms: |
|
H Phrases: | H302, H312, H315, H319, H332, H335 |
P Phrases: | P261, P264, P270, P271, P280, P301+310, P302+352, P304+340, P305+351+338, P312, P321, P330, P332+313, P337+313, P361+364, P362+364, P403+233, P405, P501 |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow.
more
You will get a certificate here
Viewed